Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Blepharoptosis (Phase 2/Phase 3)
Cardiomyopathies (Phase 2)
Coronary Artery Disease (Phase 1)
Heart Failure (Phase 2/Phase 3)
Muscular Dystrophy, Duchenne (Phase 1/Phase 2)
Muscular Dystrophy, Oculopharyngeal (Phase 2/Phase 3)
Myocardial Infarction (Phase 1)
Myocardial Ischemia (Phase 2)
Urinary Incontinence (Phase 1/Phase 2)
Urinary Incontinence, Stress (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue